Ionis Pharmaceuticals | IONS - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
Agios Pharmaceuticals USD 1.03B 83.09M 2026-06
Alnylam Pharmaceuticals USD 1.35B 278.74M 2026-06
Arrowhead Research USD 465.53M 148.45M 2026-06
Astellas Pharma JPY 1.94T 113.64B 2026-06
BioCryst Pharmaceuticals USD -454.29M 99.55M 2026-06
BioMarin Pharmaceutical USD 6.32B 109.58M 2026-06
Celltrion KRW 434.82B 1.14B 2026-03
Cspc Pharmaceutical CNY 33.18B 71.46M 2025-12
Deva Holding AS TRY 5.79B 604.07M 2023-09
Divis Laboratories Ltd INR 167.61B 13.48B 2026-03
Exelixis USD 1.84B 91.99M 2026-06
Halozyme Therapeutics USD 143.54M 76.09M 2026-06
Ionis Pharmaceuticals USD 439.74M 51.68M 2026-06
Kangmei Pharma CNY 7.31B 84.82M 2026-03
Knight Therapeutics CAD 767.27M 480K 2025-12
Laboratorios Farma EUR 539.39M 22.74M 2023-12
Malin Corporation EUR 193.2M 75M 2024-12
Medical Developments International AUD 54.77M 335K 2025-12
Moderna USD 6.76B 647M 2026-06
Nektar Therapeutics USD 576.22M 486.38M 2026-03
Neuren Pharmaceuticals AUD 338.45M 15.18M 2025-12
Neurocrine Biosciences USD 3.69B 286.2M 2026-06
Novartis USD 41.95B 3.02B 2026-06
Omeros USD -228.68M 15.13M 2025-06
OPKO Health USD 1.2B 63.35M 2026-03
Organigram Holdings CAD 371.81M 2.36M 2026-03
Ovoca Bio EUR 780K 485K 2025-12
Pfizer USD 85.19B 4.91B 2026-06
Pharma Mar EUR 250.77M 1.1M 2026-06
PTC Therapeutics USD -165.36M 15.1M 2026-06
Qiagen NV USD 3.36B 26.03M 2026-06
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Roche Holding CHF 32.69B 1.11B 2026-06
Sarepta Therapeutics USD 1.53B 22.7M 2026-06
Sartorius EUR 2.82B 96.3M 2026-06
Sino Biopharmaceutical CNY 34B 1.48B 2025-06
Tilray USD 1.58B 39.08M 2025-09
Ultragenyx Pharmaceutical USD -291M 55M 2026-06
Vertex Pharmaceuticals USD 20.25B 886M 2026-06
Zealand Pharma A/S 14.47B 361.61M 2026-03
Zz Pientze Pharmaceu CNY 14.63B 578.28M 2026-06